Galle, P. R., Bruix, J., Kloeckner, R., Trojan, J., Vogl, T. J., Ludde, T., Lampertico, P., Nault, J., Bouattour, M., Goetze, T. O., Merle, P., Saborowski, A. L., Peck-Radosavljevic, M., Ostwal, V., Pinter, M., Auriemma, A., Kudo, M., Reig, M., Al-Batran, S., Foerster, F. (2026). IKF-035/ABC-HCC: A phase IIIb, randomized, multicenter, open-label trial of atezolizumab plus bevacizumab versus transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.478